학술논문
Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study
Document Type
Article
Author
Bang, Y-J; Bendell, J; Chao, Y; Chen, J-S; Chung, H C; Davis, S L; Dev, A; Gane, E; George, B; He, A R; Hochster, H ; Hsu, C-H; Ikeda, M; Lee, J; Lee, M; Mahipal, A; Manji, G; Morimoto, M; Numata, K; Pishvaian, M ; Qin, S; Ryan, D; Ryoo, B-Y; Sasahira, N; Stein, S; Strickler, J; Tebbutt, N; Lee, Michael S; Ryoo, Baek-Yeol; Hsu, Chih-Hung; Numata, Kazushi; Stein, Stacey; Verret, Wendy; Hack, Stephen P; Spahn, Jessica; Liu, Bo; Abdullah, Heba; Wang, Yulei; He, Aiwu Ruth; Lee, Kyung-Hun
Source
In The Lancet Oncology June 2020 21(6):808-820
Subject
Language
ISSN
1470-2045